Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Physical Chemistry Chemical Physics : PCCP|November 23, 2020
Electronic and spin structures of CaMn<sub>4</sub>O<sub></sub> clusters in the S<sub>0</sub> state of the oxygen evolving complex of photosystem II. Domain-based local pair natural orbital (DLPNO) coupled-cluster (CC) calculations using optimized geometries and natural orbitals (UNO) by hybrid density functional theory (HDFT) calculationsK Miyagawa, S Yamanaka, H Isobe, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 2000
Primary carcinoid tumor in a horseshoe kidneyH Isobe, H Takashima, N Higashi, et al.
Cancer|March 15, 1990
Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancerH Isobe, H Miyamoto, T Shimizu, et al.
Internal Medicine (Tokyo, Japan)|April 1, 1996
Lymphoproliferative disorder of granular lymphocytes (natural killer cell type) with interstitial pneumonia in a patient with familial pancytopeniaT Ishida, K Sadaoka, K Takeyabu, et al.
Journal of Virology|November 1, 1993
Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1S Li, V Polonis, H Isobe, et al.
British Journal of Cancer|August 1, 1994
Retention index of thallium-201 single photon emission computerised tomography (SPECT) as an indicator of metastasis in adenocarcinoma of the lungH Takekawa, K Itoh, S Abe, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|November 1, 1989
[Clinical study of multiple primary cancers including lung cancer]A Ishikuro, H Isobe, H Miyamoto, et al.
Japanese Journal of Medicine|May 1, 1991
Myocardial metastasis from primary lung cancer: myocardial infarction-like ECG changes and pathologic findingsS Abe, N Watanabe, S Ogura, et al.
Journal of Virology|August 1, 1996
Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient miceA Bot, A Reichlin, H Isobe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Topoisomerase II alpha content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell linesK Yamazaki, H Isobe, T Hanada, et al.
Pageof 14